EP0961614A4 - Oxyalkylesters contenant de l'acide tricarboxylique et leurs utilisations - Google Patents

Oxyalkylesters contenant de l'acide tricarboxylique et leurs utilisations

Info

Publication number
EP0961614A4
EP0961614A4 EP97952599A EP97952599A EP0961614A4 EP 0961614 A4 EP0961614 A4 EP 0961614A4 EP 97952599 A EP97952599 A EP 97952599A EP 97952599 A EP97952599 A EP 97952599A EP 0961614 A4 EP0961614 A4 EP 0961614A4
Authority
EP
European Patent Office
Prior art keywords
oxyalkylesters
tricarboxylic acid
containing tricarboxylic
acid
tricarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97952599A
Other languages
German (de)
English (en)
Other versions
EP0961614A1 (fr
Inventor
Abraham Nudelman
Ada Rephaeli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bar Ilan University
Mor Research Applications Ltd
Original Assignee
Bar Ilan University
Mor Research Applications Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/781,905 external-priority patent/US6130248A/en
Application filed by Bar Ilan University, Mor Research Applications Ltd filed Critical Bar Ilan University
Publication of EP0961614A1 publication Critical patent/EP0961614A1/fr
Publication of EP0961614A4 publication Critical patent/EP0961614A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/42—Glutaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97952599A 1996-12-30 1997-12-30 Oxyalkylesters contenant de l'acide tricarboxylique et leurs utilisations Withdrawn EP0961614A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/781,905 US6130248A (en) 1996-12-30 1996-12-30 Tricarboxylic acid-containing oxyalkyl esters and uses thereof
US781905 1996-12-30
US81436597A 1997-03-11 1997-03-11
US814365 1997-03-11
PCT/US1997/023725 WO1998029114A1 (fr) 1996-12-30 1997-12-30 Oxyalkylesters contenant de l'acide tricarboxylique et leurs utilisations

Publications (2)

Publication Number Publication Date
EP0961614A1 EP0961614A1 (fr) 1999-12-08
EP0961614A4 true EP0961614A4 (fr) 2002-07-24

Family

ID=27119918

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97952599A Withdrawn EP0961614A4 (fr) 1996-12-30 1997-12-30 Oxyalkylesters contenant de l'acide tricarboxylique et leurs utilisations

Country Status (3)

Country Link
EP (1) EP0961614A4 (fr)
AU (1) AU5617398A (fr)
WO (1) WO1998029114A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228362B1 (en) 1992-08-21 2001-05-08 Immunomedics, Inc. Boron neutron capture therapy using pre-targeting methods
AU7993500A (en) * 1999-11-15 2001-05-30 New Millennium Pharmaceutical Research, Inc. Intranasal administration of raloxifene and tamoxifen
EP1170008A1 (fr) * 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Acide valproique et ses dérivés en tant qu' inhibiteurs de la déacétylase de l' histone
AUPR059400A0 (en) * 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
US6562995B1 (en) 2000-12-21 2003-05-13 Beacon Laboratories, Inc. Delta dicarbonyl compounds and methods for using the same
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
KR20050122210A (ko) 2003-03-17 2005-12-28 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
JP2008524246A (ja) 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
WO2006122319A2 (fr) 2005-05-11 2006-11-16 Takeda San Diego, Inc. Inhibiteurs d'histone deacetylase
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
DK2334378T3 (da) 2008-08-19 2014-07-07 Xenoport Inc Prodrugs af methylhydrogenfumarat, farmaceutiske sammensætninger deraf og fremgangsmåder til anvendelse
US20140348915A9 (en) 2012-08-22 2014-11-27 Xenoport, Inc. Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
JP2015527372A (ja) * 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
CN105452213B (zh) 2013-03-14 2017-09-22 阿尔克梅斯制药爱尔兰有限公司 富马酸酯前体药物及其在治疗多种疾病中的应用
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
WO2014160633A1 (fr) 2013-03-24 2014-10-02 Xenoport, Inc. Compositions pharmaceutiques de fumarate de diméthyle
US9302977B2 (en) 2013-06-07 2016-04-05 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
CA2940845C (fr) 2014-02-24 2019-09-24 Alkermes Pharma Ireland Limited Sulfonamide et promedicaments de fumarates de sulfinamide et leur utilisation dans le traitement de diverses maladies
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2017060422A1 (fr) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Métabolites protégés à base d'acide carboxylique pour le traitement des troubles mitochondriaux
WO2017060418A1 (fr) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Métabolites protégés à base d'acide carboxylique pour le traitement des maladies liées aux mitochondries
MD3762368T2 (ro) 2018-03-08 2022-07-31 Incyte Corp Compuși diol aminopirazină ca inhibitori ai PI3K-Y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) * 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
EP0276942A1 (fr) * 1987-01-27 1988-08-03 Pfizer Inc. Acides 6-bêta(substitué)-(S)-hydroxyméthylpénicillaniques et leurs dérivés
JPH06192273A (ja) * 1992-10-26 1994-07-12 Lederle Japan Ltd カルバペネム−３−カルボン酸エステル誘導体

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) * 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
EP0276942A1 (fr) * 1987-01-27 1988-08-03 Pfizer Inc. Acides 6-bêta(substitué)-(S)-hydroxyméthylpénicillaniques et leurs dérivés
JPH06192273A (ja) * 1992-10-26 1994-07-12 Lederle Japan Ltd カルバペネム−３−カルボン酸エステル誘導体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; *
PATENT ABSTRACTS OF JAPAN vol. 018, no. 542 (C - 1261) 17 October 1994 (1994-10-17) *
See also references of WO9829114A1 *

Also Published As

Publication number Publication date
EP0961614A1 (fr) 1999-12-08
WO1998029114A1 (fr) 1998-07-09
AU5617398A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
FR2737122B1 (fr) Composition stable contenant de l'acide ascorbique
EP1005562A4 (fr) Production et purification d'acide succinique
FR2727118B1 (fr) Polyorganosiloxanes fonctionnalises et l'un de leurs procedes de preparation
EP0693079A4 (fr) Derives d'acides triterpenoides et leurs utilisations
EP0856155A4 (fr) Compositions de marquage fluorescentes et luminescentes et leurs procedes d'utilisation
FR2722199B3 (fr) Derives de l'acide valproique et leurs applications comme medicaments
EP0986391A4 (fr) Composes d'oxyalkylene phosphate et leurs utilisations
EP0799495A4 (fr) Compositions silicium-germanium-carbone et processus associes
LU91437I2 (fr) "dabigatran-etexilate et ses sels- particulièrement dabigatran-etexilate-mésilate (PRADAXA)"
EP1096922A4 (fr) Compositions d'acide ascorbique topiques, stables et ameliorees
DE69323919D1 (de) Graphik-Koprozessor
FR2768733B1 (fr) Nouveaux composes 4,4-dihydroxypyrazolin-5-ones ; leurs procedes de preparation et utilisations cosmetiques
FR2727119B1 (fr) Polyorganosiloxanes fonctionnalises et l'un de leurs procedes de preparation
FR2773486B1 (fr) Composition de soin des levres contenant de l'acide acexamique, ses utilisations
EP0845457A4 (fr) Acide 2,2-dideutero-5-aminolevulinique
FR2709679B1 (fr) Compositions aqueuses concentrées d'alkylpolyglycosides et leurs utilisations.
BR9606814A (pt) Amidas de ácido alcoximinoacético
DE69606053D1 (de) Modifizierte fluorsulfonsäure
TR26214A (tr) Baryum veya stronsiyum sulfid'in lavgalanma artiklarinin hazirlanmasi.
MA23475A1 (fr) Acide 5-vinyl et 5-ethinyl -quinolone et naphtyridone -carboxyliques.
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
FR2712801B1 (fr) Structure absorbante et vêtement l'incorporant.
EP0727959A4 (fr) Utilisations diagnostiques d'hydrozinoadenosines
DE69623593D1 (de) Feststoffe enthaltend valproinsäure und natriumvalproat
FR2767693B1 (fr) Emulsion contenant de l'acide ascorbique et ses utilisations dans les domaines cosmetique et dermatologique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990730

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19990730;LT PAYMENT 19990730;LV PAYMENT 19990730;MK PAYMENT 19990730;RO PAYMENT 19990730;SI PAYMENT 19990730

A4 Supplementary search report drawn up and despatched

Effective date: 20020610

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020903